Chemical peels accelerate the removal of melanin-containing epidermal cells, compressing natural desquamation from weeks to days. A correctly timed series reduces melasma severity scores measurably over four to six sessions. Incorrectly timed or too aggressive, peels trigger post-inflammatory hyperpigmentation in the skin being treated. Depth selection, skin typing, and pre-conditioning determine which outcome follows.
What Chemical Peels Do to Pigmented Skin
Chemical peels work by applying an acidic agent to the skin at a concentration and contact time calibrated to induce controlled exfoliation at a chosen depth. The resulting shedding carries melanin-containing cells from the outer epidermis faster than the natural desquamation cycle would. The effect is a visible reduction in surface pigmentation over successive treatments.
The mechanism matters because it defines the limits of what peels can do. They clear melanin that has already been deposited in the epidermis. They do not suppress the melanocytes producing it. This is why a peel series without concurrent use of a melanogenesis inhibitor, and without strict photoprotection, typically shows a high recurrence rate once treatment ends. The NICE Clinical Knowledge Summary on melasma identifies peels as one component of a broader management approach rather than a standalone intervention.
The key variables are acid type, concentration, and contact time, alongside the practitioner's understanding of each patient's skin type and the pigmentation presentation being treated. Different acids reach different depths. Different depths carry different risk profiles, particularly in Fitzpatrick types III and above.
Understanding those variables in full is what separates practitioners who achieve consistent results from those who find peels unpredictable. The Hyperpigmentation Decoded programme covers the full assessment and sequencing framework, including where peeling fits within a structured pigmentation plan.
The Case for Autumn Peeling
August in the UK marks the end of the high-UV season. For practitioners managing hyperpigmentation, that shift in UV index creates a meaningful clinical window that opens in September and runs through to early spring.
Peels increase photosensitivity during the healing phase and in the weeks that follow. In a UK summer, ambient UV is high enough that even diligent SPF50+ use may not fully offset the risk of UV-triggered reactivation in a recently treated skin. For melasma in particular, where UV and heat are both trigger factors, the combination of fresh chemical exfoliation and late-summer sun exposure creates a predictable pathway to rebound pigmentation.
Autumn and winter remove that variable. Lower UV index, reduced recreational sun exposure, and the natural shift toward protective clothing all reduce the triggers that sustain melanocyte overactivity. A full course of four to six superficial peels at three to four week intervals can be completed between September and January, with post-course maintenance running through winter and photoprotection established as a stable daily behaviour before higher UV returns in spring.
This timing also maps well to patient expectations. Practitioners treating pigmentation in the autumn window can set a realistic schedule, frame the timeline clearly, and monitor outcomes across a full course before the risk environment changes again.
Patients presenting in August and September after summer holidays are common at this point in the year, often with visible worsening of melasma or new post-inflammatory hyperpigmentation (PIH) triggered by beach UV. Those presentations need systematic assessment before any peel decision is made. A melasma flare triggered by prolonged sun exposure requires stabilisation first, not immediate peeling.
Peel Depth and Pigment Type
Not all hyperpigmentation responds the same way to the same peel, and the choice of acid and concentration should follow a clinical decision rather than a default.
Superficial peels penetrate only the epidermis. Glycolic acid (20-70% in clinic), salicylic acid (20-30%), mandelic acid, lactic acid, and Jessner's solution all operate at this level. They are the appropriate starting point for epidermal melasma, PIH in any Fitzpatrick type, and solar lentigines. Multiple sessions build on one another, and the risk profile in trained hands is low, provided each session involves correct application technique and precise timing.
Medium-depth peels, typically trichloroacetic acid (TCA) at 35-50%, reach the upper dermis. For mixed epidermal-dermal melasma, the additional depth can clear pigment that superficial peels cannot reach, but the risk of post-peel PIH rises substantially in Fitzpatrick types III to VI. The BAD's patient information on melasma notes directly that chemical peels should be carried out by an experienced practitioner because they can worsen pigmentation as well as improve it.
In UK aesthetic practice, the majority of hyperpigmentation work sits within the superficial peel range. Medium-depth TCA peels for pigmentation indications in Fitzpatrick types III and above are generally the territory of specialist dermatology, where the expertise to manage recovery and the clinical infrastructure to handle complications are both available.
The practical decision is not which acid is strongest, but what pigment depth is present, what the skin type is, and which concentration produces measurable benefit at acceptable risk for this patient, in this consultation.
The Melasma Problem: Why Peels Require a System
Melasma has a high recurrence rate. Studies consistently show that successful treatment produces recurrence in 60-70% of cases within twelve weeks of cessation if no maintenance protocol is in place. That clinical reality shapes how peel series are most usefully deployed.
A peel course alone does not produce durable clearance of melasma. The melanocytes responsible for the pigmentation are still present and still sensitised to UV and hormonal triggers. Glycolic acid peels can reduce visible pigmentation over a course, but without a tyrosinase inhibitor maintaining suppression of melanin production between and after sessions, the cycle restarts as the new epidermis matures. The evidence for specific inhibitors is covered in detail in a recent piece in this Journal.
The evidence-supported approach for melasma involves three concurrent elements: photoprotection (SPF50+ minimum, reapplied through the day, with iron-oxide-containing formulations for complete visible light and UVA1 coverage), a melanogenesis inhibitor used consistently between sessions and continued post-course, and the peel series itself for accelerated pigment clearance. These elements are synergistic. Removing one or more weakens the others substantially.
Pre-conditioning also matters. A preparation phase of four to eight weeks using a tyrosinase inhibitor before the first peel stabilises melanocyte reactivity ahead of the controlled injury the peel produces. This principle, established in the original Kligman-Willis combination work and supported by subsequent studies, underpins why practitioners who produce consistent peel results for melasma run a topical protocol before they apply an acid.
PIH: Different Presentation, Different Protocol
Post-inflammatory hyperpigmentation responds well to superficial peels, but sequencing matters more than with melasma.
PIH follows inflammation, and the central question before any exfoliative procedure is whether the inflammatory trigger has resolved. Peeling over active acne, applying a peel to a skin still in a post-procedural inflammatory response, or treating PIH on a barrier-compromised background will frequently result in further inflammation. That deepens or extends the pigmentation rather than reducing it.
The appropriate sequence is: resolve the underlying trigger, stabilise the skin, introduce barrier-supporting topicals, begin a pre-conditioning phase with a melanogenesis inhibitor, and then introduce supervised chemical exfoliation once the skin is demonstrably calm. Moving faster than that sequence allows is the most common error in managing PIH with peels.
For Fitzpatrick types IV to VI, salicylic acid 20-30% is frequently cited as a more appropriate starting peel than glycolic acid for PIH. The anti-inflammatory properties of salicylic acid alongside its keratolytic action reduce the risk of exacerbating inflammation during the treatment itself. The lipophilic character of the molecule also makes it useful where PIH is associated with post-acne or follicular pigmentation. The absolute contraindication to aggressive peeling in darker skin types is not the skin type itself. It is insufficient assessment and inadequate expertise in the hands performing the procedure.
Contraindications Practitioners Need to Check
Several presentations require either absolute avoidance of chemical peeling or significant modification to the standard approach.
Active isotretinoin use (and recent use, within the preceding six to twelve months): isotretinoin reduces sebaceous secretion and alters the barrier in ways that make chemical exfoliation disproportionately aggressive. This contraindication is well established and not a grey area.
Recent ablative laser or IPL treatment: the skin requires full recovery before any additional chemical exfoliation. The interval depends on the treatment received, but the general principle is that competing injury timelines need to be separated.
Herpes simplex history: facial peels can precipitate an oral or perioral HSV outbreak. Antiviral prophylaxis is standard practice before medium-depth procedures; for patients with a documented history, the same consideration applies to superficial peels at higher concentrations.
Active rosacea: the inflammatory background and compromised barrier make glycolic acid peels particularly poorly tolerated. Salicylic acid at lower concentrations, with careful monitoring, may be appropriate in stable papulopustular rosacea, but active disease is a caution flag, not clearance.
Pregnancy: several common peel adjuncts and melanogenesis inhibitors are contraindicated in pregnancy. When a patient is pregnant, pigmentation management is limited, and chemical exfoliation for cosmetic pigmentation is generally deferred to post-delivery and post-breastfeeding.
Putting It Together: What Autumn Consultations Should Cover
An autumn hyperpigmentation consultation headed toward a peel series should include: Fitzpatrick skin type assessment and Wood's lamp examination to establish pigment depth, a full triggers assessment (hormonal status, contraception, HRT, recent UV history), a review of current skincare and any existing depigmenting agents, a realistic timeline for the course (September through January accommodates a six-session series comfortably), and an explicit conversation about what the peel series can and cannot achieve independently.
Patients arriving after a summer holiday with a visible melasma flare or new PIH need the presentation stabilised before any peel is scheduled. A post-holiday flare is not a starting point for chemical exfoliation. It is a starting point for photoprotection, barrier restoration, and the topical inhibitor phase that precedes the peel course.
The practitioners who achieve the most consistent outcomes with peels for hyperpigmentation are the ones who do the assessment work thoroughly before committing to a procedure. The free pigment quiz is a useful patient-facing tool for initial triage: it surfaces the key variables before a face-to-face consultation.
For the full clinical framework behind hyperpigmentation assessment, depth classification, and treatment sequencing, Hyperpigmentation Decoded covers the same NICE-aligned approach used in Bernadette's clinic across the range of presentations practitioners encounter. The programme is £150 with lifetime access. A free entry point for practitioners earlier in their pigmentation training is the free Hyperpigmentation mini-course, which introduces the classification and assessment framework before the paid programme's full clinical depth.
FAQ
Is autumn the only time to perform chemical peels for hyperpigmentation in the UK?
It is not the only time, but it is the most clinically logical window for completing a full course. Lower UV index, reduced recreational sun exposure, and better SPF compliance in cooler months reduce the primary triggers that sustain and reactivate hyperpigmentation. Superficial peels can be performed at other times of year, but patient selection criteria and post-procedure management are more demanding during high-UV months.
Can a course of chemical peels permanently clear melasma?
No. Melasma is a chronic condition with a high recurrence rate. Peels can produce significant reductions in melasma area severity scores over a course, but without continued photoprotection and melanogenesis inhibitor use, recurrence is the expected outcome. The peel course is one phase of an ongoing management plan, not a curative procedure.
What peel depth is appropriate for Fitzpatrick type V or VI skin?
Superficial peels, in particular salicylic acid 20-30%, are the more appropriate starting point for PIH in darker skin types because of the anti-inflammatory component alongside the keratolytic action. Medium-depth TCA peels carry a substantial risk of post-peel PIH in Fitzpatrick types V and VI and are not a standard first-line approach. Practitioners who work regularly with diverse skin types and have the clinical experience to manage complications may extend the range, but skin typing accuracy and complication management expertise are central to that decision.
How many peel sessions does a hyperpigmentation course typically require?
Superficial peels for epidermal pigmentation typically require four to six sessions at three to four week intervals to produce a visible and sustained response. Solar lentigines may respond faster. Mixed melasma and longstanding PIH often require longer courses and consistent maintenance thereafter. Single sessions rarely produce a meaningful or durable outcome.
Should patients pause their skincare before a peel?
Active retinoids are typically paused for several days before a superficial peel, and for longer before a medium-depth procedure. Patients on a pre-conditioning protocol with a tyrosinase inhibitor should continue that through the peel series. Those on no active skincare may benefit from a preparation phase before the first session. Each consultation before a peel should include a current skincare review to identify anything that warrants adjustment.
Does a chemical peel remove the need for SPF in a pigmentation protocol?
No. Photoprotection is non-negotiable throughout any pigmentation management plan. Accelerating epidermal turnover while leaving the primary UV trigger unmanaged is a cycle, not a treatment. SPF50+ applied in the morning and reapplied through the day is the baseline on which everything else in the protocol depends.